STRATA Skin Sciences Inc

Company Profile

STRATA Skin Sciences Inc had its IPO on 2005-10-28 under the ticker symbol SSKN.

The company operates in the Healthcare sector and Medical Devices industry. STRATA Skin Sciences Inc has a staff strength of 114 employees.

Stock update

Shares of STRATA Skin Sciences Inc opened at $0.57 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.57 - $0.6, and closed at $0.57.

This is a -2.86% slip from the previous day's closing price.

A total volume of 3,138 shares were traded at the close of the day’s session.

In the last one week, shares of STRATA Skin Sciences Inc have slipped by -11.83%.

STRATA Skin Sciences Inc's Key Ratios

STRATA Skin Sciences Inc has a market cap of $20.60 million, indicating a price to book ratio of 1.3937 and a price to sales ratio of 0.8526.

In the last 12-months STRATA Skin Sciences Inc’s revenue was $35.83 million with a gross profit of $19.85 million and an EBITDA of $258000. The EBITDA ratio measures STRATA Skin Sciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, STRATA Skin Sciences Inc’s operating margin was -14.51% while its return on assets stood at -5.98% with a return of equity of -36.37%.

In Q2, STRATA Skin Sciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 9.4%.

STRATA Skin Sciences Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

-0.02

Its diluted EPS in the last 12-months stands at $-0.21 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -0.02. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into STRATA Skin Sciences Inc’s profitability.

STRATA Skin Sciences Inc stock is trading at a EV to sales ratio of 0.9037 and a EV to EBITDA ratio of -6256.733. Its price to sales ratio in the trailing 12-months stood at 0.8526.

STRATA Skin Sciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$55.20 million

Total Liabilities

$14.12 million

Operating Cash Flow

$0

Capital Expenditure

$931000

Dividend Payout Ratio

0%

STRATA Skin Sciences Inc ended 2025 with $55.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $55.20 million while shareholder equity stood at $16.91 million.

STRATA Skin Sciences Inc ended 2025 with $306000.00 in deferred long-term liabilities, $14.12 million in other current liabilities, 35000.00 in common stock, $-233211000.00 in retained earnings and $8.80 million in goodwill. Its cash balance stood at $9.03 million and cash and short-term investments were $9.03 million. The company’s total short-term debt was $392,000 while long-term debt stood at $14.99 million.

STRATA Skin Sciences Inc’s total current assets stands at $21.25 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $4.40 million compared to accounts payable of $3.88 million and inventory worth $5.92 million.

In 2025, STRATA Skin Sciences Inc's operating cash flow was $0 while its capital expenditure stood at $931000.

Comparatively, STRATA Skin Sciences Inc paid $0 in dividends in 2025.

Other key metrics

Current Trading Price

$0.57

52-Week High

$1.39

52-Week Low

$0.45

Analyst Target Price

$3.9

STRATA Skin Sciences Inc stock is currently trading at $0.57 per share. It touched a 52-week high of $1.39 and a 52-week low of $1.39. Analysts tracking the stock have a 12-month average target price of $3.9.

Its 50-day moving average was $0.8 and 200-day moving average was $0.93 The short ratio stood at 4.19 indicating a short percent outstanding of 0%.

Around 406.8% of the company’s stock are held by insiders while 6676% are held by institutions.